Molecular Characterization and Antibiotic Susceptibility Pattern of Staphylococcus aureus Isolated from Clinical and Environmental Sources by Ayepola, O.O
MOLECULAR CHARACTERIZATION AND 
ANTIBIOTIC SUSCEPTIBILITY PATTERN OF 
Staphylococcus aureus ISOLATED FROM CLINICAL 
AND ENVIRONMENTAL SOURCES 
 
 
 
 
 
 
 
 
BY 
 
 
 
 
 
 
 
 
 
AYEPOLA, OLAYEMI OLUSEUN 
 
(CUGP050133) 
 
 
 
 
 
A Ph.D THESIS SUBMITTED 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE AWARD 
OF DOCTOR OF PHILOSOPHY (Ph.D) DEGREE IN MICROBIOLOGY OF 
THE DEPARTMENT OF BIOLOGICAL SCIENCES (MICROBIOLOGY UNIT) 
SCHOOL OF NATURAL AND APPLIED SCIENCES, COLLEGE OF SCIENCE 
AND TECHNOLOGY, COVENANT UNIVERSITY, OTA, OGUN STATE, 
NIGERIA. 
 
 
 
 
 
 
 
 
 
 
SEPTEMBER, 2012 
ABSTRACT 
Staphylococcus aureus is an important pathogen causing skin and soft-tissue infections, 
systemic infections and toxemic syndromes. In order to have adequate information for 
treatment of S.aureus infections, it is important to understand trends in the antibiotic-
resistance patterns as well as clonal identities across geographical regions. A total of 297 
non-duplicate S. aureus isolates (209 clinical, 84 carrier and 4 environmental) were 
characterized by phenotypic and genomic methods. Antimicrobial susceptibility testing was 
performed by disk diffusion and the automated VITEK-2 system. PCR was used to amplify 
genes for accessory gene regulator (agr); capsular polysaccharide (cap) 5 and 8, exfoliative 
toxins (eta and etb), the toxic shock syndrome toxin-1(tst) and Panton-Valentine Leukocidin 
(PVL). Typing of isolates was by the staphylococcal protein A (spa) typing. High level 
resistance was observed against penicillin and ampicillin (97.3%); 
trimethoprim/sulfamethoxazole (80%) and tetracycline (17.5%). Azithromycin, 
clarithromycin, erythromycin, clindamycin, linezolid, vancomycin, nitrofurantoin, fusidic 
acid, mupirocin and rifampicin recorded 100% activity against the isolates. Ninety-five 
percent of all strains (n=281) harboured the β-lactamase (blaZ) gene and 2.7% (n=8) 
possessed the mecA gene. The methicillin resistant S. aureus (MRSA) strains were resistant 
to at least 10 antibiotics including all penicillins, penicillin/penicillinase inhibitor 
combinations, carbapenem and cephalosporins. The staphylococcal cassette chromosome mec 
(SCCmec) typing of MRSA strains detected only SCCmec types I and IV in two strains 
(Y260: type I and Y59: type IV). The eta and tst genes were present in 0.7% (n=2) and 1.7% 
(n=5) of S. aureus isolates respectively. A high prevalence of PVL genes was noted in 
clinical isolates (79.4%; n=166); carrier isolates (56%; n=47) and environmental isolates 
(75%; n=3). The PVL protein was expressed in vitro by 68.5% of strains harboring lukS-PV 
and lukF-PV gene. All strains carried either the cap8 (91.9%; n=273) or cap5 locus (7.7%; 
n=23) while one MRSA strain was untypeable. A Single agr allele was detected in each S. 
aureus isolate with the majority in agr-2 (73.4%; n=218). Thirty-seven spa types were 
identified; predominant spa types among the methicillin-susceptible S. aureus (MSSA) were 
t084 (65%), t2304 (4.4%) and t8435 (4%). Prevalent spa types in MRSA were t002, t008, 
t064, t194, t8439, t8440 and t8441. Eleven novel spa types (t8435, t8436, t8437, t8438, 
t8439, t8440, t8441, t8442, t8952, t8953, t8953) were identified. The pT181 plasmid was 
successfully used to confer tetracycline resistance in S. aureus strains A56 and Y1. The use 
of phenotypic and molecular methods in this study provided useful information on antibiotic 
resistance and genetic diversity of S. aureus isolates from Ogun and Lagos States of Nigeria. 
The information provided could help in monitoring the evolution of S. aureus strains in 
Nigeria over 
time. 
